Frost & Sullivan Lauds RF Co., Ltd. for Its Groundbreaking Digital Radiography Products

LONDON, July 27, 2010 – Based on its recent research on the digital radiography market, Frost &
Sullivan presents RF Co., Ltd. with the "2010 European Medical Technologies
Product Leadership of the Year Award," for NAOMI, a digital x-ray sensor that
does not require any film development to acquire x-ray film images.

(Logo: photos.prnewswire.com/prnh/20081117/FSLOGO)
[...]

QPS Announces the Acquisition of Xendo Drug Development

This European Acquisition Expands QPS' Global Capabilities
NEWARK, Delaware and GRONINGEN, Netherlands, July 26, 2010 – QPS Holdings, LLC, a leading full-service GLP/GCP-compliant contract
research organization providing testing services to support preclinical and
clinical research and development, announced the completion of its
acquisition of Xendo Drug Development BV (XDD), headquartered in Groningen,
The Netherlands. XDD, a European contract research [...]

Will Anyone be Normal?

Diagnosis and the DSM-5: Proposed Changes to Diagnostic Best Practice Offer a Staggering Range of 'New' Conditions. Sir Terry Pratchett and Others Weigh in on the Impact of Mental Health Diagnosis and the Ever-Shrinking Idea of Normalcy

LONDON, July 27, 2010 – This month Journal of Mental Health features a special issue on
diagnosing mental illness. [...]

Animal Experiments Statistics Total 3.6 Million – “a Shameful Legacy of Science’s Complacency About Animal Suffering”

Humane Society International has reacted strongly to Home Office statistics released today revealing no significant decrease in animal experiments conducted in Britain, still totalling 3.6 million experiments in 2009

LONDON, July 27, 2010 – The Home Office emphasises that most procedures were on rodents (82
percent), but HSI research (see below) reveals mice and rats often [...]

Health Robotics Surpasses 100 Installations Milestone and Acquires Two I.V. Room of the Future Partner Companies

BOZEN, SUD-TIROL, Italy, July 27, 2010 – Health Robotics announced that it has reached final agreements to acquire
all assets from Italy-based MEDarchiver S.r.l. and Biomedical Technology
Consulting S.r.l., merging these companies' employees and operations,
re-entering direct sales activities in the Italian market, and conducting a
re-organization of its Executive Management, expecting to close these
acquisitions over the next [...]

Hospitals in India Experience Downward Pricing

SEBASTIAN, Florida, July 27, 2010 – This month, as predicted in the February 2008 issue of the PHM Emerging
Markets Healthcare Monitor, insurance companies in India announced that they
would only work with hospitals that meet their pricing demands. These firms
control nearly 70% of the Indian health insurance market.

Hank Kearney, president of [...]

Bionovo to Advance Menerba to Phase 3 Clinical Testing in Europe

EMERYVILLE, California, July 29, 2010 – Bionovo, Inc. (Nasdaq: BNVI) announced today that it has received final
guidance from the European Medicines Agency (EMA) in order to advance
Menerba, the company's lead drug candidate for menopausal symptoms, to Phase
3 clinical trials in Europe. The guidance defines the clinical and regulatory
pathway to a European marketing authorization for [...]

Simbionix Continues its Global Expansion

CLEVELAND, Ohio, July 28, 2010 – Simbionix USA Corporation, the world's leading provider of medical
education and simulation training products for medical professionals and the
healthcare industry, is pleased to announce the company's continued global
expansion. Simbionix has increased the size of two of its major facilities
with an expansion of its Corporate Headquarters in Cleveland, OH, and [...]

Liquent Unveils the Results of its Regulatory Affairs Trends Survey

Regulatory Professionals Contribute to this Global Insight into Regulatory Trends

HORSHAM, Pennsylvania, July 28, 2010 – Liquent, Inc. ("Liquent") is pleased to announce the findings of its 2009
Liquent Regulatory Affairs Trends Survey. The survey attracted respondents
from across the globe representing small, medium and large life sciences
companies and provides a unique insight into emerging and future [...]

Boston Scientific Launches Neuroform EZ(TM) Stent System in U.S. and Europe

Company Expands Market-leading Family of Neurovascular Stents
NATICK, Massachusetts, July 28, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced the
U.S. and European launches of the Neuroform EZ(TM) Stent System, its
fourth-generation intracranial aneurysm stent system designed for use in
conjunction with endovascular coiling to treat wide-necked aneurysms. The
Company plans to launch the product immediately in both [...]

Bupa Appoints bigmouthmedia to Search Marketing Account

EDINBURGH, Scotland, July 28, 2010 – Leading international healthcare provider, Bupa, has selected
bigmouthmedia, Europe's largest and most experienced digital marketing
agency, to lead its search marketing strategy.

The new deal will see bigmouthmedia take on a major search engine
optimisation programme which will involve Bupa's key UK websites. The
project, which will be the [...]

Torchmark Corporation Reports Second Quarter 2010 Results

MCKINNEY, Texas, July 28, 2010 – Torchmark Corporation (NYSE: TMK) reported today that for the quarter
ended June 30, 2010, net income was US$1.53 per share compared with US$1.38
per share for the year-ago quarter. Net operating income for the quarter was
US$1.58 per share, a 3% per share increase compared with US$1.53 per share
for the year-ago [...]

Elsevier and PANGAEA Take Next Step in Connecting Research Articles to Data

Elsevier Articles now Graphically Enriched With Information From PANGAEA Data Sets

AMSTERDAM, July 29, 2010 – Elsevier, a world-leading publisher of scientific, technical and
medical information products and services, and PANGAEA – Publishing Network
for Geoscientific & Environmental Data – today announced their next step in
interconnecting the diverse elements of scientific research. Elsevier
articles at ScienceDirect are now [...]

Cardio3 BioSciences Hosts Visiting Scientist

This press release is issued to clarify a Cardio3 BioSciences release of July 14, 2010.

MONT-SAINT-GUIBERT, Belgium, July 29, 2010 – Cardio3 BioSciences, a leading Belgian biotechnology company specialising
in regenerative therapies for the treatment of cardiovascular diseases, today
announces that Atta Behfar, M.D. Ph.D, of Mayo Clinic in Rochester,
Minnesota, USA will spend a portion of his [...]